Loading clinical trials...
Loading clinical trials...
Randomized, Double-Blind, Double-Dummy, 5-Way Crossover Study to Evaluate the Abuse Potential of Cenobamate Relative to Alprazolam and Placebo When Administered Orally in Non-Dependent, Recreational Drug Users with Sedative Experience
Conditions
Interventions
Alprazolam Placebo
Cenobamate placebo
+2 more
Locations
2
United States
Vince & Associates Clinical Research, Inc
Overland Park, Kansas, United States
INC Research, Inc.
Toronto, Ontario, Canada
Start Date
March 8, 2017
Primary Completion Date
November 18, 2017
Completion Date
December 15, 2017
Last Updated
November 7, 2024
NCT07310264
NCT00090662
NCT06342713
NCT06223555
NCT07472361
NCT01266577
Lead Sponsor
SK Life Science, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions